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Reply, Santer Reply, Turin, ITALY Aim: Chemotherapy can be safely administered at home through chronomodulated delivery over the 24 hours via a programmable pump, with improved tolerability and efficacy (Lévi F, Annu Rev Pharm Toxicol 2010) . The purpose of the study was to further increment safety through the detection of early warning signals predicting for hospitalization through daily telemonitoring of multidimensional objective and subjective data.
Methods:
Telemonitoring involved daily self-assessment of body weight, symptoms (M.D. Anderson Symptom Inventory, MDASI), and recording of circadian rest-activity rhythm through a wrist accelerometer (AMI). Data were received in a server, and visualized daily by the medical/nursing staff using a web app. Alarm thresholds were adjusted according to body weight loss, weighted MDASI symptoms according to sparse linear discriminant analysis SLDA, and dichotomy index I<O, a measure of circadian disruption corresponding to the percentage of minutes In-bed with activity being lower than the median activity Out-of-bed (Innominato P, Cancer Res 2009). Results: 37 patients (Male/Female, 57% / 43%), aged 35-91 years were followed for a median duration of 63 (34-246) days from October 2011 to August 2013. The majority of patients had been previously treated for metastatic cancer of the colon (43%), pancreas (26%) or breast (13%). Out of 98 chrono-chemotherapy courses at home (1-16 per patient; chronoFOLFIRINOX for 46% patients), 12 led to emergency hospitalizations in 6/37 patients (16%). Hospitalizations lasted a cumulated span of 72 days (2-9 per patient) among 2330 patient-days on study (3.1%). Retrospective analysis identified 3 relevant alerts within the 7 days before hospitalization: body weight loss ≥5%; I<O <95%; and a linear combination of weighted MDASI scores >4. The combination of circadian disruption and high weighted MDASI score predicted hospitalization for 4/6 patients (67%) and occurred in 0/31 non-hospitalized patients (Fisher's exact test p < 0.003). Conclusions: Multidimensional telemonitoring of circadian rest-activity rhythm and weighted symptoms provided effective detection of risk for emergency hospitalization in patients on chronomodulated chemotherapy at home. These biomarkers are integrated for validation in a multicenter patient-centered prospective assessment of domomedicine (PiCADo). Disclosure: All authors have declared no conflicts of interest.
